AgingResearch.NewsJoin free

Tissue-engineered nucleus pulposus

Intervention

1 paper1 finding

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 1 country
  • Funders: China Postdoctoral Science Foundation and 5 more
  • Animals1

Outcomes

1

Tissue regeneration

upin animals1

1 study

  1. Tissue-engineered nucleus pulposus improves tissue regeneration.

    “combination of NP-MTs and the DNPM-MA hydrogel yielded superior tissue regeneration outcomes both in vitro and in vivo”

    Animalsin vitro and in vivo

    Bottom-up engineering of the nucleus pulposus using a photocrosslinkable decellularized matrix hydrogel attenuates inflammaging and enhances microtissue-mediated regeneration

    Materials today. Bio24 Sep 2025

Latest

Related